1. Home
  2. LNTH vs OLED Comparison

LNTH vs OLED Comparison

Compare LNTH & OLED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNTH
  • OLED
  • Stock Information
  • Founded
  • LNTH 1956
  • OLED 1985
  • Country
  • LNTH United States
  • OLED United States
  • Employees
  • LNTH N/A
  • OLED N/A
  • Industry
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • OLED Semiconductors
  • Sector
  • LNTH Health Care
  • OLED Technology
  • Exchange
  • LNTH Nasdaq
  • OLED Nasdaq
  • Market Cap
  • LNTH 7.5B
  • OLED 7.2B
  • IPO Year
  • LNTH 2015
  • OLED 1992
  • Fundamental
  • Price
  • LNTH $79.78
  • OLED $153.11
  • Analyst Decision
  • LNTH Strong Buy
  • OLED Strong Buy
  • Analyst Count
  • LNTH 5
  • OLED 7
  • Target Price
  • LNTH $133.80
  • OLED $190.43
  • AVG Volume (30 Days)
  • LNTH 1.4M
  • OLED 700.0K
  • Earning Date
  • LNTH 05-07-2025
  • OLED 05-01-2025
  • Dividend Yield
  • LNTH N/A
  • OLED 1.18%
  • EPS Growth
  • LNTH N/A
  • OLED 4.58
  • EPS
  • LNTH 3.53
  • OLED 4.81
  • Revenue
  • LNTH $1,536,699,000.00
  • OLED $648,702,000.00
  • Revenue This Year
  • LNTH $4.96
  • OLED $5.35
  • Revenue Next Year
  • LNTH $10.25
  • OLED $13.88
  • P/E Ratio
  • LNTH $22.59
  • OLED $31.80
  • Revenue Growth
  • LNTH 12.53
  • OLED 6.13
  • 52 Week Low
  • LNTH $74.34
  • OLED $103.70
  • 52 Week High
  • LNTH $126.89
  • OLED $237.00
  • Technical
  • Relative Strength Index (RSI)
  • LNTH 29.82
  • OLED 66.62
  • Support Level
  • LNTH $77.01
  • OLED $139.13
  • Resistance Level
  • LNTH $83.60
  • OLED $157.57
  • Average True Range (ATR)
  • LNTH 3.74
  • OLED 5.44
  • MACD
  • LNTH -2.67
  • OLED 2.85
  • Stochastic Oscillator
  • LNTH 8.68
  • OLED 87.97

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

About OLED Universal Display Corporation

Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.

Share on Social Networks: